Samil Pharmaceutical Co Ltd
KRX:000520
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Samil Pharmaceutical Co Ltd
KRX:000520
|
KR |
|
Ventas Inc
NYSE:VTR
|
US |
|
BBTV Holdings Inc
TSX:BBTV
|
CA |
|
M
|
Microelectronics Technology Inc
TWSE:2314
|
TW |
|
S
|
SBW Life Sciences Co Ltd
KOSDAQ:151910
|
KR |
|
Elicio Therapeutics Inc
NASDAQ:ELTX
|
US |
|
Holland Colours NV
AEX:HOLCO
|
NL |
|
Aramark
NYSE:ARMK
|
US |
|
W
|
Wing Yip Food Holdings Group Ltd
KOSDAQ:900340
|
HK |
|
Y
|
YeaRimDang Publishing Co Ltd
KOSDAQ:036000
|
KR |
|
D
|
DevPort AB
STO:DEVP B
|
SE |
Wall Street
Price Targets
Price Targets Summary
Samil Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Samil Pharmaceutical Co Ltd is 13 260 KRW with a low forecast of 13 130 KRW and a high forecast of 13 650 KRW.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Samil Pharmaceutical Co Ltd's stock price target?
Price Target
13 260
KRW
According to Wall Street analysts, the average 1-year price target for Samil Pharmaceutical Co Ltd is 13 260 KRW with a low forecast of 13 130 KRW and a high forecast of 13 650 KRW.
What is Samil Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
9%
For the last 13 years the compound annual growth rate for Samil Pharmaceutical Co Ltd's revenue is 7%. The projected CAGR for the next 3 years is 9%.
What is Samil Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
255%
The compound annual growth rate of Samil Pharmaceutical Co Ltd's operating income for the next 3 years is 255%.
